NCBI PubMed Central
open access
Targeting pathogenic immune cells in rheumatoid arthritis: emerging immunotherapeutic frontiers.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Targeting the synovial engine: next-generation engineered immune cells to eradicate pathogenic FLS in rheumatoid arthritis, with safety-first, selective designs.#399732
- Immunometabolism and rheumatic disease-advancing targeted therapies#1204006
- Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis#1250736
- Integrating transcriptomic analysis to explore biomarkers and therapeutic targets for rheumatoid arthritis: a case-control and systems biology approach.#1404190
- Resolution of inflammation: A novel therapeutic paradigm for rheumatoid arthritis and its comorbidities#1250978
Record · ID 1404245
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive